Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Bodine P. S. Belderbos"'
Autor:
Bodine P. S. Belderbos, Mirjam de With, Rajbir K. Singh, Bram C. Agema, Samira El Bouazzaoui, Esther Oomen-de Hoop, Ronald de Wit, Ron H. N. van Schaik, Ron H. J. Mathijssen, Sander Bins
Publikováno v:
Cancer Chemotherapy & Pharmacology, 85(3), 547-553. Springer-Verlag
Purpose: Cabazitaxel, used in patients with metastatic castration-resistant prostate cancer (mCRPC), is associated with adverse events which may require dose reductions or discontinuation of treatment. We investigated the potential association of sin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47ff41a3c6b9dc529cd92610958b089d
https://doi.org/10.1007/s00280-019-04011-0
https://doi.org/10.1007/s00280-019-04011-0
Autor:
Bodine P S, Belderbos, Mirjam, de With, Rajbir K, Singh, Bram C, Agema, Samira, El Bouazzaoui, Esther, Oomen-de Hoop, Ronald, de Wit, Ron H N, van Schaik, Ron H J, Mathijssen, Sander, Bins
Publikováno v:
Cancer chemotherapy and pharmacology. 85(3)
Cabazitaxel, used in patients with metastatic castration-resistant prostate cancer (mCRPC), is associated with adverse events which may require dose reductions or discontinuation of treatment. We investigated the potential association of single-nucle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::449bddcf8f161fbde0c251766b32c2ea
https://pubmed.ncbi.nlm.nih.gov/31893292
https://pubmed.ncbi.nlm.nih.gov/31893292